« “These results indicate that all patients with PV may be eligible for ropeg therapy independent of their genetic makeup,” the authors wrote.
Germline Factors Affect Molecular Response to Tr... - MPN Voice
Germline Factors Affect Molecular Response to Treatment for Polycythemia Vera
Written by
Manouche
To view profiles and participate in discussions please or .
1 Reply
•
In my opinion it will depends on the metabolism too because if you have a poor metabolism maybe the drug cant affect you or, in other hand, if you have a fast metabolism, maybe it can affect your body.
The article dosent say anything about it.
Not what you're looking for?
You may also like...
Recombinant Interferon-β in the Treatment of Polycythemia Vera
Simple Summary:
« The myeloproliferative neoplasms (MPNs) are chronic blood cancers...
Targeted Therapies for Polycythemia Vera
« Andrew Kuykendall, MD:
You bring up a great point there as far as the durability goes, because I...
Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment
« The main goal of the trial is the proportion of patients who achieve a complete hematologic...
FDA Issues Complete Response Letter for Ropeginterferon Alfa-2b for Polycythemia Vera
« The FDA has issued a complete response letter regarding the biologics license application for...
Why is it critical to achieve a deep molecular response ?
»Reaching a Deep Molecular Remission is now considered a goal of therapy by many clinicians. The...
Related Posts
Observational REVEAL Study Highlights Potential Risk Factors for Disease Transformation in Polycythemia Vera
FDA Approves Ropeginterferon Alfa-2b-njft for Polycythemia Vera- FDA Rejects Ropeginterferon alfa-2b for Polycythemia Vera
- INTERFERON-ALPHA TREATMENT RESULTS IN THE DEPLETION OF DORMANT JAK2-MUTANT HSC IN A MURINE MODEL OF POLYCYTHEMIA VERA
- Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
